The FDA filed two suits against unproven stem cell clinic firms in 2018 seeking permanent injunctions against them including US Stem Cell in Florida and Cell Surgical Network, et al. here in California. There’s been a major new development in this story that I see as good news. Court rejects US Stem Cell clinic appeal […]
US Stem Cell clinic loses appeal, could impact pending Cali case? Read More »
The journal Stem Cells Translational Medicine has a long track record of publishing great work. I also have a lot of respect for the editors there and I’ve published there myself. But a few recent events have sparked concerns including over possible undisclosed conflicts of interest in some papers there about cord blood for autism.
Cord conflicts at the journal Stem Cells Translational Medicine Read More »
This was a busy week for me working on a grant due Friday and a bunch of other stuff including happily analyzing a bunch of data, but there were tons of interesting papers recently including on pluripotency. California stem cell clinic court case on in the background Along the way this week I was occasionally
Weekly reads: court case, cancer stem cells, skin, pluripotency, & more Read More »
Mere weeks into the COVID pandemic, stunning graphics began to appear depicting the path of devastation of SARS-CoV-2 through a human lung. It’s only recently that we’ve come to understand what, exactly, is happening on a cellular level. The new view is thanks to single-cell RNA-sequencing, which analyzes the abundance of messenger RNAs in individual
COVID Traps Alveoli Cells in a Curious Progenitor State, Squelching Lung Regeneration Read More »
Does it make any sense medically or scientifically to use stem cell therapy for pain or neuropathy? There isn’t much solid evidence that this is a good way to go. However, there’s a vast scope of research ongoing in this area. Stem cell clinics have been earning millions of dollars selling this idea too. The
Fact-check of stem cell therapy for pain & neuropathy Read More »
One of my main research interests is in oncodevelopmental factors. These include factors that are important both for normal stem cell biology and development as well as driving cancer when misregulated. One example includes the MYC family of proto-oncogenes. When I was a postdoc I got especially interested in trying to understand the normal role
Weekly reads: oncodevelopmental factors, iPSC cancer vaccine, more Read More »
I got some great entries for our The Niche stem cell picture contest. While I expected many bright colorful images, every year some of the pictures surprise me in certain ways. There was another surprise in that two entrants in the contest, both Assistant Professors, are sisters. A talented family! You can see the previous
The Niche stem cell picture contest winners: gut & astrocytes Read More »
Stem cell clinic firm US Stem Cell has just had a major paper retracted. Two of the notable authors on that paper are US Stem Cell leader Kristin Comella and stem cell researcher Thomas Ichim, who was senior author. It’s not clear to me if Comella currently has a role in the firm or not.
Stem cell clinic US Stem Cell has key paper retracted Read More »
Stem cell clinics violating federal regulations have been a major problem for the FDA. Next month the FDA faces a historic moment on this problem. A grace period for clinics to become FDA compliant ends in May. Even so, it appears that hundreds of clinics will remain non-compliant after that. Some of the worst clinics
I’m going to start off today’s recommended reads post with some stem cells for vision developments. I had some fun the last 2 weeks as people sent in their entries for our $100 stem cell picture contest. I’ll announce the winner this week. It’s going to be hard to choose given the great entries. Stem
Weekly reads: Stem cells for vision loss & recommended pubs Read More »